BPC 157 Dosing and Administration - Injectable, Oral and Reconstitution Guide
BPC 157 is available in two primary administration formats: subcutaneous injectable and oral capsules. Both deliver the same peptide, but they differ in bioavailability, target tissue concentration, and clinical application. Understanding these differences, along with proper reconstitution and injection technique, helps you follow your prescribed protocol accurately and safely.
Important: BPC 157 is not FDA approved. It is prescribed and compounded through licensed pharmacies, and its compounding status is under FDA review in 2026.
- BPC 157 is available as subcutaneous injectable (preferred for systemic tissue repair, tendon and ligament healing, and maximum bioavailability) and oral capsules (preferred for gut healing applications)
- There is no FDA approved or clinically validated dose. Ranges discussed in clinical practice commonly fall in the low hundreds of micrograms daily, and your physician sets your specific dose based on injury type and severity
- Oral capsule ranges discussed in practice are similar, with some protocols suggesting an empty stomach for GI absorption, though this is based on practice rather than controlled data
- Injectable BPC 157 arrives as lyophilized powder requiring reconstitution with bacteriostatic water before use
- Reconstituted BPC 157 should be refrigerated immediately and used within 21 to 28 days; never freeze reconstituted peptide
- Injection timing is flexible, but many protocols recommend morning and evening dosing for twice daily protocols, or before bed for single daily dosing
- Your physician determines the appropriate route, dose, and frequency based on your specific condition, healing goals, and treatment timeline
Injectable vs. Oral: How to Choose
The choice between injectable and oral BPC 157 depends on what you are treating and where in the body the repair is needed.
Injectable BPC 157 delivers the peptide systemically through the bloodstream, reaching all tissues including tendons, ligaments, muscles, joints, and organs. It provides the highest bioavailability and is the preferred route for musculoskeletal injuries, post surgical recovery, and conditions where systemic tissue repair is the goal. Subcutaneous injection near (though not necessarily at) the injury site can provide both systemic and localized benefit.
Oral BPC 157 capsules deliver the peptide directly to the gastrointestinal tract, where it can act locally on the gut lining before any systemic absorption. This makes oral BPC 157 the preferred route for IBS, leaky gut, inflammatory bowel symptoms, gastric mucosal damage, and other GI conditions where direct contact with the gut tissue is therapeutically important.
Combination protocols using injectable for systemic effects and oral capsules for concurrent gut healing are common and often produce the most comprehensive results for patients with both musculoskeletal and GI concerns.
For the complete comparison of absorption, bioavailability, and clinical applications by route, see Injectable vs Oral BPC 157 and Oral BPC 157 Capsules: Usage, Dosing, and Safety.
Ranges Discussed in Clinical Practice
These ranges are discussed in clinical and community practice and are not FDA validated. They are context for a conversation with your physician, who sets your actual dose.
For complete syringe calculation tables, reconstitution step by step instructions, and worked examples for every common vial configuration, see the BPC 157 Dosage Calculator.
Reconstitution for Injectable BPC 157
Injectable BPC 157 arrives as lyophilized powder requiring reconstitution with bacteriostatic water. The standard syringe calculation formula using a U 100 insulin syringe: divide your desired dose in mcg by the concentration in mcg per ml, then multiply by 100.
Reconstitution rules: bacteriostatic water only. Never shake the vial, roll gently to dissolve. Solution should be clear and colorless. Refrigerate immediately after reconstitution and use within 21 to 28 days. Never freeze reconstituted BPC 157.
Injection Technique
BPC 157 is administered subcutaneously into fatty tissue beneath the skin. Preferred injection sites are the abdomen (at least 2 inches from navel), outer thigh, and outer upper arm. Some physicians recommend injecting near the injury site to provide both local and systemic benefit.
Rotate injection sites daily for twice daily protocols and with every injection for once daily protocols. The technique is standard: clean the site with an alcohol swab, allow to dry, pinch a fold of skin, insert needle at 45 to 90 degrees, inject slowly, remove and apply gentle pressure without rubbing, and dispose of the needle in a sharps container.
For the complete practical guide to optimizing your peptide therapy process, see 7 Tips to Maximize Peptide Recovery.
Frequently Asked Questions
Should I choose injectable or oral BPC 157?
Injectable for musculoskeletal healing and systemic repair. Oral for gut healing. Combined for patients with both concerns. Your physician determines the most appropriate route at assessment.
Can I take BPC 157 with food?
Oral BPC 157 is best taken on an empty stomach for optimal GI tract absorption. Injectable BPC 157 is not affected by food intake.
How long should I use BPC 157?
A typical treatment cycle is 8 to 12 weeks. Some patients use shorter cycles for acute injuries and longer or repeated cycles for chronic conditions. Your physician advises on duration based on your response and goals.
Can I combine BPC 157 with TB 500?
BPC 157 and TB 500 are commonly used together in stacking protocols because they work through complementary mechanisms. BPC 157 drives angiogenesis and growth factor modulation locally, while TB 500 promotes systemic cellular migration and anti inflammatory effects. Combination protocols require physician supervision. Visit TB500.org to learn more.
Disclaimer
This content is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. BPC 157 is available through licensed U.S. compounding pharmacies via physician prescription. Compounded medications are not FDA reviewed for safety, quality, or efficacy as finished products. Consult a licensed healthcare provider before starting, changing, or stopping any treatment. Individual results vary.